Applied Clinical Trials
August 01, 2013
View from Brussels
22
8
The EMA is committed not just to greater accessibility of data, but proactive publication.
August 01, 2013
Risk-Based Monitoring in Clinical Trials
22
8
Central statistical monitoring can improve RBM solutions by efficiently detecting errors, sloppiness, tampering, and fraud.
August 01, 2013
News
22
8
Everyone is looking to rev up the biopharmaceutical development pipeline, and the FDA is working hard to do its part.
August 01, 2013
Risk-Based Monitoring in Clinical Trials
22
8
The reality of risk-based monitoring: history and successful implementation for late phase research.
August 01, 2013
News
22
8
The implementation of best practices for clinical study and development conduct can streamline administrative burdens for investigator staff as well as study teams, and hopefully yield reduced costs in conducting global clinical development.
August 01, 2013
News
22
8
Are clinical trial data shared sufficiently today?
August 01, 2013
Feature Article
22
8
Survey appraises the use of SOPs in clinical research from the sponsors' point of view.
August 01, 2013
A Closing Thought
22
8
The goal is to have an evidence development framework that can answer a range of questions simultaneously.
August 01, 2013
Feature Article
22
8
The eClinical Forum Risk Based Monitoring Taskforce offers some best practices for ensuring clinical data quality.
August 01, 2013
Risk-Based Monitoring in Clinical Trials
22
8
The use of RBM may be the only way forward as long as the development of medicines relies on clinical testing.
August 01, 2013
Risk-Based Monitoring in Clinical Trials
22
8
Risk-based monitoring ushers in the move from the traditional experimental design.
August 01, 2013
Business News
22
8
Industry news focusing on the people and organizations who work in the clinical trials profession.
August 01, 2013
CTI Insights
22
8
The next 18 to 24 months may bring profound changes for investigative sites.
July 01, 2013
Issue PDF
22
8
Trial Design: Risk-based Approaches: Best Practices for Ensuring Clinical Data Quality Regulatory: Clinical Research SOPs Also in this issue: Transparency in Europe Fragmented Study Conduct Landscape Comprehensive Evidence Development